Recruiting ADHD Studies in Largo
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)...
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
The purpose of the study in Part 1 (dose escalation) and in Part 2 (dose expansion) is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) and evaluate preliminary clinical efficacy. Part 3 (dose...
About ADHD Clinical Trials in Largo
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.
There are currently 2 adhd clinical trials recruiting participants in Largo, FL. These studies are seeking a combined 716 participants. Research is being sponsored by Ferring Pharmaceuticals, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
ADHD Clinical Trials in Largo — FAQ
Are there adhd clinical trials in Largo?
Yes, there are 2 adhd clinical trials currently recruiting in Largo, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Largo?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Largo research site will contact you about next steps.
Are clinical trials in Largo free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Largo studies also compensate for your time and travel.
What adhd treatments are being tested?
The 2 active trials in Largo are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.
Data updated March 2, 2026 from ClinicalTrials.gov